Results 121 to 130 of about 26,891 (150)
Some of the next articles are maybe not open access.
Ischemia-Modified Albumin Predicts Mortality in ESRD
American Journal of Kidney Diseases, 2006The primary study aim is to determine whether ischemia-modified albumin (IMA) levels predict mortality in patients with end-stage renal disease (ESRD). The secondary aim is to determine characteristics of patients with elevated IMA levels.A prospective observational study of 114 renal transplantation candidates was performed.
Rajan, Sharma +7 more
openaire +2 more sources
Ischemia-modified albumin levels in cerebrovascular accidents
The American Journal of Emergency Medicine, 2008Previous studies have demonstrated that ischemia-modified albumin (IMA) is a useful marker for the diagnosis of ischemic events. It was also recently demonstrated that IMA levels increase in the acute phase of cerebrovascular diseases. Yet the data regarding IMA levels in various types of cerebrovascular events are insufficient.
Abdulkadir, Gunduz +9 more
openaire +2 more sources
Kinetics of Ischemia-Modified Albumin Following Exercise-Induced Myocardial Ischemia
Clinical Laboratory, 2016Ischemia-modified albumin (IMA) is a potentially valuable biochemical marker of myocardial ischemia. The aim of our study was to define the kinetics and to determine the diagnostic value of IMA in detection of myocardial ischemia by using a model of exercise-stress induced transitory ischemia.The study included 43 consecutive patients with positive ...
Bakula, Miro +5 more
openaire +3 more sources
Ischemia-Modified Albumin is not Elevated in Deep Venous Thrombosis
Clinical Laboratory, 2015In this article, we aimed to determine the diagnostic role of ischemia-modified albumin (IMA) in the evaluation of patients with deep venous thrombosis (DVT).Fifty-five patients with a diagnosis of DVT and 47 healthy subjects as the control group were included in the study. Blood samples of the patients were obtained within the first 24 hours after DVT
Ereren, Emrah +4 more
openaire +2 more sources
Ischemia modified albumin in ischemic disorders.
2009n ...
LIPPI, Giuseppe, MONTAGNANA, Martina
openaire +2 more sources
The ischemia-modified albumin biomarker for myocardial ischemia.
MLO: medical laboratory observer, 2003Ischemia-modified albumin is the first biomarker for myocardial ischemia to be approved by the FDA. Other markers are being evaluated such as free fatty acids, pregnancy-associated plasma protein-A, glycogen phosphorylase isoenzyme BB, sphingosine-1-phosphate and whole blood choline.
openaire +1 more source
[Ischemia-modified albumin: new marker of myocardial ischemia?].
Casopis lekaru ceskych, 2005The Albumin Cobalt Binding Test is a quantitative in vitro diagnostic test used on human serum that detects ischemia-modified albumin by measuring the cobalt binding capacity of albumin in human serum. Ischemia modified albumin is intended for use in conjunction with ECG and cardiac troponin as an aid to short term risk stratification of patients ...
J, Dusek +6 more
openaire +1 more source
Ischemia-modified albumin in patients with seizure
The American Journal of Emergency Medicine, 2014Sevket, Balta +4 more
openaire +2 more sources
Ischemia modified albumin in cardiovascular disease
The American Journal of Emergency Medicine, 2016Sevket, Balta +5 more
openaire +2 more sources
Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism
European Journal of Internal Medicine, 2014Varikasuvu Seshadri, Reddy +4 more
openaire +2 more sources